{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:22:27Z","timestamp":1784334147683,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ucl.2019.07.001","type":"journal-article","created":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T23:00:12Z","timestamp":1566169212000},"page":"467-473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Hormone Therapy for Transgender Adults"],"prefix":"10.1016","volume":"46","author":[{"given":"Asa","family":"Radix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ucl.2019.07.001_bib1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/15532739.2011.700873","article-title":"Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7","volume":"13","author":"Coleman","year":"2011","journal-title":"Int J Transgend"},{"issue":"10042","key":"10.1016\/j.ucl.2019.07.001_bib2","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0140-6736(16)00683-8","article-title":"Transgender people: health at the margins of society","volume":"388","author":"Winter","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ucl.2019.07.001_bib3","series-title":"The report of the 2015 U.S. transgender survey","author":"James","year":"2016"},{"issue":"1","key":"10.1016\/j.ucl.2019.07.001_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10461-007-9299-3","article-title":"Estimating HIV prevalence and risk behaviors of transgender persons in the United States: a systematic review","volume":"12","author":"Herbst","year":"2008","journal-title":"AIDS Behav"},{"key":"10.1016\/j.ucl.2019.07.001_bib5","series-title":"California lesbians, gays, bisexuals, and transgender tobacco use survey - 2004","author":"Bye","year":"2005"},{"issue":"1","key":"10.1016\/j.ucl.2019.07.001_bib6","first-page":"e1","article-title":"Estimating the prevalence of HIV and sexual behaviors among the US transgender population: a systematic review and meta-analysis, 2006-2017","volume":"109","author":"Becasen","year":"2019","journal-title":"Am J PublicHealth"},{"key":"10.1016\/j.ucl.2019.07.001_bib7","series-title":"National transgender discrimination survey report on health and health care","author":"Grant","year":"2010"},{"issue":"12","key":"10.1016\/j.ucl.2019.07.001_bib8","first-page":"44","article-title":"Mental health and the transgender population","volume":"54","author":"Carmel","year":"2016","journal-title":"J\u00a0PsychosocNursMent Health Serv"},{"issue":"11","key":"10.1016\/j.ucl.2019.07.001_bib9","first-page":"2191","article-title":"Gender abuse and major depression among transgender women: a prospective study of vulnerability and resilience","volume":"104","author":"Nuttbrock","year":"2014","journal-title":"Am J PublicHealth"},{"issue":"5","key":"10.1016\/j.ucl.2019.07.001_bib10","first-page":"943","article-title":"Stigma, mental health, and resilience in an online sample of the US transgender population","volume":"103","author":"Bockting","year":"2013","journal-title":"Am J PublicHealth"},{"issue":"5","key":"10.1016\/j.ucl.2019.07.001_bib11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1037\/0033-2909.129.5.674","article-title":"Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: conceptual issues and research evidence","volume":"129","author":"Meyer","year":"2003","journal-title":"Psychol Bull"},{"issue":"4","key":"10.1016\/j.ucl.2019.07.001_bib12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10935-017-0469-4","article-title":"Demographic characteristics, components of sexuality and gender, and minority stress and their associations to excessive alcohol, cannabis, and illicit (noncannabis) drug use among a large sample of transgender people in the United States","volume":"38","author":"Gonzalez","year":"2017","journal-title":"J\u00a0Prim Prev"},{"issue":"12","key":"10.1016\/j.ucl.2019.07.001_bib13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11920-018-0973-0","article-title":"Gender-affirming hormone use in transgender individuals: impact on behavioral health and cognition","volume":"20","author":"Nguyen","year":"2018","journal-title":"Curr Psychiatry Rep"},{"issue":"1","key":"10.1016\/j.ucl.2019.07.001_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/09540261.2015.1115753","article-title":"Mental health and gender dysphoria: a review of the literature","volume":"28","author":"Dhejne","year":"2016","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.ucl.2019.07.001_bib15","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jad.2018.02.051","article-title":"Levels of depression in transgender people and its predictors: results of a large matched control study with transgender people accessing clinical services","volume":"235","author":"Witcomb","year":"2018","journal-title":"J\u00a0Affect Disord"},{"issue":"Suppl12B","key":"10.1016\/j.ucl.2019.07.001_bib16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.amjmed.2005.09.059","article-title":"Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration","volume":"118","author":"Stefanick","year":"2005","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.ucl.2019.07.001_bib17","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-19-0071","article-title":"ENDOCRINE HISTORY: the history of discovery, synthesis and development of testosterone for clinical use","volume":"180","author":"Nieschlag","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ucl.2019.07.001_bib18","series-title":"The transsexual phenomenon","author":"Benjamin","year":"1966"},{"issue":"11","key":"10.1016\/j.ucl.2019.07.001_bib19","first-page":"3869","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an endocrine society* clinical practice guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J\u00a0ClinEndocrinolMetab"},{"key":"10.1016\/j.ucl.2019.07.001_bib20","article-title":"Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People","author":"UCSF Transgender Care","year":"2016"},{"key":"10.1016\/j.ucl.2019.07.001_bib21","series-title":"Blueprint for the provision of comprehensive care for trans people and trans communities","year":"2015"},{"key":"10.1016\/j.ucl.2019.07.001_bib22","series-title":"Blueprint for the provision of comprehensive care for trans persons and their communities in the Caribbean and other Anglophone countries","author":"Pan American Health Organization [PAHO] JS, Inc","year":"2014"},{"key":"10.1016\/j.ucl.2019.07.001_bib23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/14681994.2014.883353","article-title":"Good practice guidelines for the assessment and treatment of adults with Gender Dysphoria","volume":"29","author":"Wylie","year":"2014","journal-title":"Sexual and Relationship Therapy"},{"key":"10.1016\/j.ucl.2019.07.001_bib24","article-title":"Guidelines for gender affirming healthcare for gender diverse and transgender children, young people and adults in Aotearoa, New Zealand","author":"Oliphant","year":"2018","journal-title":"Transgender Health Research Lab, University of Waikato"},{"key":"10.1016\/j.ucl.2019.07.001_bib25","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"1","key":"10.1016\/j.ucl.2019.07.001_bib26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/09540261.2015.1091293","article-title":"Gender incongruence\/gender dysphoria and its classification history","volume":"28","author":"Beek","year":"2016","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.ucl.2019.07.001_bib27","series-title":"International classification of diseases ICD-11: classifying disease to map the way we live and die. Coding disease and death","author":"World Health Organization","year":"2018"},{"issue":"6","key":"10.1016\/j.ucl.2019.07.001_bib28","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.3928\/00904481-20140522-10","article-title":"Beyond the guidelines: challenges, controversies, and unanswered questions","volume":"43","author":"Radix","year":"2014","journal-title":"Pediatr Ann"},{"issue":"4","key":"10.1016\/j.ucl.2019.07.001_bib29","doi-asserted-by":"crossref","first-page":"256","DOI":"10.7326\/M17-0577","article-title":"Cardiovascular disease among transgender adults receiving hormone therapy: a narrative review","volume":"167","author":"Streed","year":"2017","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.ucl.2019.07.001_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1373\/clinchem.2018.288241","article-title":"Effects of gender-affirming hormones on lipid, metabolic, and cardiac surrogate blood markers in transgender persons","volume":"65","author":"Defreyne","year":"2019","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.ucl.2019.07.001_bib31","first-page":"253","article-title":"Endocrine treatment of aging transgender people","volume":"19","author":"Gooren","year":"2018","journal-title":"Rev EndocrMetabDisord"},{"issue":"4","key":"10.1016\/j.ucl.2019.07.001_bib32","first-page":"619","article-title":"Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women","volume":"85","author":"Vehkavaara","year":"2001","journal-title":"ThrombHaemost"},{"issue":"7","key":"10.1016\/j.ucl.2019.07.001_bib33","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ucl.2019.07.001_bib34","first-page":"3132","article-title":"Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline","volume":"94","author":"Hembree","year":"2009","journal-title":"J\u00a0ClinEndocrinolMetab"},{"issue":"4","key":"10.1016\/j.ucl.2019.07.001_bib35","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/EJE-10-1038","article-title":"A\u00a0long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones","volume":"164","author":"Asscheman","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.ucl.2019.07.001_bib36","first-page":"2349","article-title":"Subcutaneous injection of testosterone is an effective and preferred\u00a0alternative to intramuscular injection: demonstration in female-to-male transgender patients","volume":"102","author":"Spratt","year":"2017","journal-title":"J\u00a0ClinEndocrinolMetab"},{"issue":"6","key":"10.1016\/j.ucl.2019.07.001_bib37","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/AOG.0000000000000540","article-title":"Transgender men who experienced pregnancy after female-to-male gender transitioning","volume":"124","author":"Light","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ucl.2019.07.001_bib38","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.contraception.2018.06.006","article-title":"Family planning and contraception use in transgender men","volume":"98","author":"Light","year":"2018","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.ucl.2019.07.001_bib39","first-page":"231","article-title":"Fertility preservation options in transgender people: A review","volume":"19","author":"Mattawanon","year":"2018","journal-title":"Rev EndocrMetabDisord"},{"issue":"6","key":"10.1016\/j.ucl.2019.07.001_bib40","first-page":"575","article-title":"Transgenderism and reproduction","volume":"20","author":"T'Sjoen","year":"2013","journal-title":"CurrOpinEndocrinol Diabetes Obes"},{"issue":"4","key":"10.1016\/j.ucl.2019.07.001_bib41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M17-2785","article-title":"Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study","volume":"169","author":"Getahun","year":"2018","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ucl.2019.07.001_bib42","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ecl.2019.02.006","article-title":"Osteoporosis and bone health in transgender persons","volume":"48","author":"Stevenson","year":"2019","journal-title":"EndocrinolMetabClin North Am"},{"issue":"1","key":"10.1016\/j.ucl.2019.07.001_bib43","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bone.2013.01.039","article-title":"Low bone mass is prevalent in male-to-female transsexual persons before the start of cross-sex hormonal therapy and gonadectomy","volume":"54","author":"Van Caenegem","year":"2013","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.ucl.2019.07.001_bib44","first-page":"434","article-title":"Breast cancer screening, management, and a review of case study literature in transgender populations","volume":"35","author":"Deutsch","year":"2017","journal-title":"SeminReprod Med"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014319300485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014319300485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:36:32Z","timestamp":1758807392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014319300485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0094014319300485"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2019.07.001","relation":{},"ISSN":["0094-0143"],"issn-type":[{"value":"0094-0143","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hormone Therapy for Transgender Adults","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2019.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}